The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
Clinical trial NCT04670107 · COMPLETED
Trial details
- NCT number
- NCT04670107
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.